Baird Medical Investment Holdings Limited(BDMD)Earnings, Financials & Key Ratios

BDMD•NASDAQ

$1.78

$65M mkt cap·3.6× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryImaging, radiation, and oncology devices

AboutBaird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.Show more

Revenue$37M+17.7%
EBITDA$17M+30.6%
Net Income$12M+18.1%
EPS (Diluted)0.49+19.5%
Gross Margin88.16%+1.9%
EBITDA Margin45.42%+11.0%
Operating Margin41.35%+9.7%
Net Margin33.62%+0.3%
ROE33%-3.8%
ROIC22.57%-4.1%
Debt/Equity0.53+89.4%
Interest Coverage26.55-36.4%

Technical→

BDMD Key Insights

Baird Medical Investment Holdings Limited (BDMD) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Excellent 3Y average ROE of 49.8%
✓Strong 5Y sales CAGR of 24.8%
✓Healthy 5Y average net margin of 36.9%
✓Trading at only 1.1x book value

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

BDMD Price & Volume

Baird Medical Investment Holdings Limited (BDMD) stock price & volume — 10-year historical chart

Loading chart...

BDMD Growth Metrics

Baird Medical Investment Holdings Limited (BDMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years24.85%

3 Years10.14%

TTM-

Profit CAGR

10 Years-

5 Years-

3 Years2.17%

TTM-

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM-

Return on Capital

10 Years72.08%

5 Years72.79%

3 Years46.04%

Last Year37.78%

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
NVCRNovoCure LimitedDirect Competitor	1.88B	16.50	-13.52	8.28%	-25.66%	-50.82%	0.85
ARAYAccuray IncorporatedDirect Competitor	58.45M	0.49	-31.75	2.68%	-10.76%	-77.48%	2.17
AEYEAudioEye, Inc.Direct Competitor	95.09M	7.66	-30.64	14.52%	-7.63%	-47.8%	0.15
ELMDElectromed, Inc.Direct Competitor	214.77M	25.94	30.16	16.97%	13.06%	19.79%	0.00
HLITHarmonic Inc.Product Competitor	1.37B	12.18	36.91	11.65%	7.81%	11.2%	0.32
IRTCiRhythm Technologies, Inc.Product Competitor	3.87B	117.70	-84.68	26.24%	-3.53%	-20.6%	4.79
INVAInnoviva, Inc.Product Competitor	1.91B	22.52	6.82	18.52%	118.91%	46.47%	0.23
MDTMedtronic plcSupply Chain	99.48B	77.60	21.50	3.62%	13%	9.45%	0.59

Compare BDMD vs Peers

Baird Medical Investment Holdings Limited (BDMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NVCR

Most directly comparable listed peer for BDMD.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare BDMD against a more recognizable public peer.

Peer Set

Compare Top 5

vs NVCR, ARAY, AEYE, ELMD

BDMD Income Statement

Baird Medical Investment Holdings Limited (BDMD) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24
Sales/Revenue	12.21M	18.12M	27.72M	35.09M	31.46M	37.04M
Revenue Growth %	-	48.39%	52.99%	26.58%	-10.35%	17.74%
Cost of Goods Sold	1.3M	2.51M	4.54M	7.05M	4.23M	4.38M
COGS % of Revenue	10.63%	13.86%	16.39%	20.1%	13.44%	11.84%
Gross Profit	10.91M▲ 0%	15.61M▲ 43.0%	23.18M▲ 48.5%	28.04M▲ 21.0%	27.23M▼ 2.9%	32.65M▲ 19.9%
Gross Margin %	89.37%	86.14%	83.61%	79.9%	86.56%	88.16%
Gross Profit Growth %	-	43.03%	48.49%	20.96%	-2.88%	19.92%
Operating Expenses	5.3M	5.75M	9.76M	13.03M	15.37M	17.34M
OpEx % of Revenue	43.43%	31.72%	35.2%	37.13%	48.85%	46.81%
Selling, General & Admin	4.15M	5M	10.22M	10.55M	11.09M	9.96M
SG&A % of Revenue	33.96%	27.58%	36.87%	30.05%	35.27%	26.9%
Research & Development	1.16M	750.48K	1.04M	3.86M	4.27M	6.17M
R&D % of Revenue	9.46%	4.14%	3.75%	11%	13.59%	16.67%
Other Operating Expenses	0	0	0	0	0	1.2M
Operating Income	5.61M▲ 0%	9.86M▲ 75.8%	11.92M▲ 20.8%	13.63M▲ 14.4%	11.86M▼ 13.0%	15.32M▲ 29.1%
Operating Margin %	45.94%	54.42%	42.99%	38.85%	37.71%	41.35%
Operating Income Growth %	-	75.79%	20.84%	14.39%	-12.98%	29.11%
EBITDA	5.96M	10.47M	13.32M	15.1M	12.88M	16.82M
EBITDA Margin %	48.8%	57.79%	48.04%	43.04%	40.93%	45.42%
EBITDA Growth %	-	75.72%	27.17%	13.4%	-14.74%	30.65%
D&A (Non-Cash Add-back)	349.14K	609.55K	1.4M	1.47M	1.01M	1.51M
EBIT	5.5M	9.67M	12.76M	14.82M	11.86M	14.66M
Net Interest Income	-89.62K	-159.47K	-151.59K	-290.72K	-284.27K	-576.36K
Interest Income	0	0	2.33K	8.55K	0	393
Interest Expense	89.62K	159.47K	153.92K	299.27K	284.27K	576.75K
Other Income/Expense	-11.46M	-283.25K	688.35K	890.15K	497.48K	-1.23M
Pretax Income	-5.85M▲ 0%	9.58M▲ 263.8%	12.61M▲ 31.6%	14.52M▲ 15.2%	12.36M▼ 14.9%	14.09M▲ 14.0%
Pretax Margin %	-47.89%	52.86%	45.47%	41.38%	39.29%	38.04%
Income Tax	1.28M	2.43M	2.42M	1.75M	1.7M	1.49M
Effective Tax Rate %	-21.96%	25.33%	19.22%	12.03%	13.76%	10.57%
Net Income	-7.18M▲ 0%	7.1M▲ 198.8%	11.68M▲ 64.5%	12.57M▲ 7.6%	10.55M▼ 16.1%	12.45M▲ 18.1%
Net Margin %	-58.83%	39.18%	42.12%	35.82%	33.52%	33.62%
Net Income Growth %	-	198.83%	64.46%	7.64%	-16.09%	18.09%
Net Income (Continuing)	-7.13M	7.15M	10.18M	12.77M	10.66M	12.6M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	-683.77K	-448.7K	-356.73K	-155.59K	-43.39K	101.34K
EPS (Diluted)	-1.00▲ 0%	0.99▲ 198.8%	-0.02▼ 102.4%	0.02▲ 189.7%	0.41▲ 1789.4%	0.49▲ 19.5%
EPS Growth %	-	198.83%	-102.45%	189.67%	1789.4%	19.51%
EPS (Basic)	-1.00	0.99	-0.02	0.02	0.41	0.49
Diluted Shares Outstanding	7.19M	7.19M	7.19M	7.19M	7.58M	25.63M
Basic Shares Outstanding	7.19M	7.19M	7.19M	6.29M	7.58M	25.56M
Dividend Payout Ratio	-	-	46.47%	-	-	-

BDMD Balance Sheet

Baird Medical Investment Holdings Limited (BDMD) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24
Total Current Assets	8.67M	13.05M	22.4M	33.76M	40.08M	61.42M
Cash & Short-Term Investments	257.08K	1.14M	3.44M	1.91M	1.63M	2.97M
Cash Only	220.45K	1.07M	3.03M	1.71M	1.51M	2.97M
Short-Term Investments	36.62K	65.11K	407.5K	197K	120.48K	0
Accounts Receivable	4.56M	8.23M	12.45M	24.76M	31.49M	46.58M
Days Sales Outstanding	136.28	165.78	163.89	257.58	365.42	459.03
Inventory	709.47K	810.07K	3.06M	1.29M	1.14M	1.3M
Days Inventory Outstanding	199.41	117.75	245.44	66.91	98.65	107.97
Other Current Assets	3.05M	620.89K	304.29K	197K	120.48K	295.75K
Total Non-Current Assets	3.09M	3.97M	3.72M	8.85M	16.63M	16.55M
Property, Plant & Equipment	1.66M	2.84M	3.33M	2.73M	7M	7.62M
Fixed Asset Turnover	7.35x	6.37x	8.34x	12.86x	4.49x	4.86x
Goodwill	60.61K	64.65K	66.17K	61.14K	59.38K	57.77K
Intangible Assets	143.62K	107.23K	62.77K	49.48K	25.48K	16.53K
Long-Term Investments	0	0	-108.14K	-206.22K	-814.37K	0
Other Non-Current Assets	1.23M	951.01K	190.08K	5.81M	10.36M	8.14M
Total Assets	11.76M▲ 0%	17.02M▲ 44.7%	26.12M▲ 53.5%	42.62M▲ 63.1%	56.71M▲ 33.1%	77.96M▲ 37.5%
Asset Turnover	1.04x	1.06x	1.06x	0.82x	0.55x	0.48x
Asset Growth %	-	44.71%	53.51%	63.15%	33.06%	37.48%
Total Current Liabilities	33.61M	9.25M	9.77M	16.02M	18.98M	34.62M
Accounts Payable	100.25K	61.12K	340.21K	215.86K	550.19K	1.25M
Days Payables Outstanding	28.18	8.88	27.33	11.17	47.5	104.31
Short-Term Debt	28.09M	2.45M	2.04M	6.23M	8.17M	17.03M
Deferred Revenue (Current)	0	0	701.53K	692.51K	499.9K	792.1K
Other Current Liabilities	3.33M	5.41M	29.91K	20.32K	93.39K	45.24K
Current Ratio	0.26x	1.41x	2.29x	2.11x	2.11x	1.77x
Quick Ratio	0.24x	1.32x	1.98x	2.03x	2.05x	1.74x
Cash Conversion Cycle	307.52	274.65	382.01	313.32	416.57	462.69
Total Non-Current Liabilities	728.29K	1M	494.12K	816.88K	2.03M	3.58M
Long-Term Debt	0	0	0	0	0	3.44M
Capital Lease Obligations	692.38K	974.29K	494.12K	816.88K	412.12K	136.68K
Deferred Tax Liabilities	0	0	0	0	0	0
Other Non-Current Liabilities	35.9K	26.81K	0	0	1.61M	0
Total Liabilities	34.33M	10.25M	10.26M	16.84M	21M	38.2M
Total Debt	28.94M	4.05M	2.93M	7.44M	9.9M	20.88M
Net Debt	28.72M	2.98M	-97.6K	5.73M	8.39M	17.91M
Debt / Equity	-	0.60x	0.61x	0.29x	0.28x	0.53x
Debt / EBITDA	4.86x	0.39x	0.22x	0.49x	0.77x	1.24x
Net Debt / EBITDA	4.82x	0.28x	-0.01x	0.38x	0.65x	1.06x
Interest Coverage	62.60x	61.84x	77.42x	45.55x	41.73x	26.55x
Total Equity	-22.58M▲ 0%	6.76M▲ 130.0%	4.85M▼ 28.3%	25.78M▲ 431.9%	35.71M▲ 38.5%	39.76M▲ 11.4%
Equity Growth %	-	129.96%	-28.34%	431.86%	38.52%	11.35%
Book Value per Share	-3.14	0.94	0.67	3.59	4.71	1.55
Total Shareholders' Equity	-21.89M	7.21M	5.2M	25.93M	35.75M	39.66M
Common Stock	0	0	11.64K	2.94K	2.94K	2.56K
Retained Earnings	-15.67M	-9.62M	-7.13M	3.96M	14.39M	26.76M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	-6.22M	16.83M	3.31M	3.12M	2.5M	1.45M
Minority Interest	-683.77K	-448.7K	-356.73K	-155.59K	-43.39K	101.34K

BDMD Cash Flow Statement

Baird Medical Investment Holdings Limited (BDMD) cash flow — operating, investing & free cash flow history

Line item	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24
Cash from Operations	4.41M	3.91M	5.26M	485.97K	-1.02M	-6.31M
Operating CF Margin %	36.12%	21.56%	18.96%	1.38%	-3.24%	-17.05%
Operating CF Growth %	-	-11.42%	34.5%	-90.75%	-309.88%	-518.95%
Net Income	-7.18M	7.1M	10.18M	12.77M	10.55M	12.6M
Depreciation & Amortization	638.1K	1.07M	1.4M	1.47M	1.38M	1.51M
Stock-Based Compensation	0	0	0	0	0	0
Deferred Taxes	0	0	-45.38K	-143.32K	0	32.77K
Other Non-Cash Items	12.93M	-613.53K	286.05K	433.58K	1.11M	1.25M
Working Capital Changes	-1.98M	-3.65M	-6.57M	-14.05M	-14.05M	-21.7M
Change in Receivables	59.31K	-3.76M	-3.49M	-14.1M	-9.67M	-17.8M
Change in Inventory	-392.08K	-61.28K	-2.2M	1.57M	113.66K	-187.54K
Change in Payables	0	0	274.31K	-100.93K	0	727.8K
Cash from Investing	1.18M	-2.17M	-1.39M	-5.92M	-2.64M	-2.85M
Capital Expenditures	-983.78K	-655.35K	-1.39M	-5.91M	-2.64M	-2.85M
CapEx % of Revenue	8.06%	3.62%	5.01%	16.84%	8.39%	7.7%
Acquisitions	0	0	0	0	0	0
Investments	-	-	-	-	-	-
Other Investing	2.17M	-1.52M	561	-12.16K	0	0
Cash from Financing	-5.72M	-899.08K	-1.93M	4.41M	3.46M	10.72M
Debt Issued (Net)	-395.09K	-269.62K	-88.58K	4.46M	2.35M	10.31M
Equity Issued (Net)	0	0	0	0	0	1000K
Dividends Paid	0	0	-5.43M	0	0	0
Share Repurchases	0	0	0	0	0	0
Other Financing	-5.32M	-629.46K	3.59M	-46.4K	1.11M	-2.49M
Net Change in Cash	220.45K▲ 0%	850.81K▲ 285.9%	1.96M▲ 130.4%	-1.32M▼ 167.4%	-200.44K▲ 84.8%	1.46M▲ 828.2%
Free Cash Flow	3.43M▲ 0%	3.25M▼ 5.1%	3.87M▲ 18.9%	-5.47M▼ 241.4%	-3.66M▲ 33.1%	-9.17M▼ 150.6%
FCF Margin %	28.06%	17.94%	13.95%	-15.58%	-11.63%	-24.75%
FCF Growth %	-	-5.12%	18.94%	-241.39%	33.1%	-150.56%
FCF per Share	0.48	0.45	0.54	-0.76	-0.48	-0.36
FCF Conversion (FCF/Net Income)	-0.61x	0.55x	0.45x	0.04x	-0.10x	-0.51x
Interest Paid	92.78K	95.9K	90.08K	243.84K	261.32K	497.25K
Taxes Paid	0	0	3.91M	1.44M	0	1.84M

BDMD Key Ratios

Baird Medical Investment Holdings Limited (BDMD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	104.97%	201.14%	82.08%	34.3%	33%
Return on Invested Capital (ROIC)	68.52%	93.13%	123.35%	56.4%	23.53%	22.57%
Gross Margin	89.37%	86.14%	83.61%	79.9%	86.56%	88.16%
Net Margin	-58.83%	39.18%	42.12%	35.82%	33.52%	33.62%
Debt / Equity	-	0.60x	0.61x	0.29x	0.28x	0.53x
Interest Coverage	62.60x	61.84x	77.42x	45.55x	41.73x	26.55x
FCF Conversion	-0.61x	0.55x	0.45x	0.04x	-0.10x	-0.51x
Revenue Growth	-	48.39%	52.99%	26.58%	-10.35%	17.74%

BDMD Frequently Asked Questions

Baird Medical Investment Holdings Limited (BDMD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Baird Medical Investment Holdings Limited (BDMD) reported $37.0M in revenue for fiscal year 2024. This represents a 203% increase from $12.2M in 2019.

Baird Medical Investment Holdings Limited (BDMD) grew revenue by 17.7% over the past year. This is strong growth.

Yes, Baird Medical Investment Holdings Limited (BDMD) is profitable, generating $12.5M in net income for fiscal year 2024 (33.6% net margin).

Dividend & Returns

Baird Medical Investment Holdings Limited (BDMD) has a return on equity (ROE) of 33.0%. This is excellent, indicating efficient use of shareholder capital.

Baird Medical Investment Holdings Limited (BDMD) had negative free cash flow of $9.2M in fiscal year 2024, likely due to heavy capital investments.

Explore More BDMD

Baird Medical Investment Holdings Limited (BDMD) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Baird Medical Investment Holdings Limited(BDMD)Earnings, Financials & Key Ratios

BDMD Key Insights

✓Strengths

✗Weaknesses

BDMD Price & Volume

BDMD Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

BDMD Peer Comparison

Compare BDMD vs Peers

vs NVCR

vs ISRG

Compare Top 5

BDMD Income Statement

BDMD Balance Sheet

BDMD Cash Flow Statement

BDMD Key Ratios

BDMD Frequently Asked Questions

Explore More BDMD

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation